44:90:09:01.  Mandatory testing prior to transfer for retail sale. A medical cannabis establishment must test every batch of cannabis or cannabis product intended for retail sale in final form prior to transfer. Any alterations made by a medical cannabis establishment after receipt of cannabis or cannabis product results in the creation of a new final form.

    The following tests are required for cannabis and cannabis products:

    (1)  Potency for tetrahydrocannabinol (THC) content and, if so labeled, cannabidiol content. The allowed variance for THC content may not exceed plus or minus ten percent;

    (2)  Microbials listed in subdivision 44:90:05:10(3);

    (3)  Mycotoxins listed in subdivision 44:90:05:10(2);

    (4)  Metals listed in subdivision 44:90:05:10(4) and § 44:90:07:03;

    (5)  Pesticides listed in subdivision 44:90:05:10(1); and

    (6)  Solvents listed in § 44:90:07:03.

    Source: 48 SDR 40, effective October 5, 2021; 49 SDR 9, effective August 8, 2022; 50 SDR 62, effective November 27, 2023.

    General Authority: SDCL 34-20G-72(4)(d)(e)(l).

    Law Implemented: SDCL 34-20G-72(4)(d)(e)(l).